Taylor Sandison - Dec 29, 2021 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
Chief Medical Officer
Signature
/s/ Taylor Sandison
Stock symbol
CDTX
Transactions as of
Dec 29, 2021
Transactions value $
$0
Form type
4
Date filed
1/7/2022, 07:22 PM
Previous filing
Oct 4, 2021
Next filing
Apr 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Options Exercise $0 +15.6K +6.48% $0.00 256K Dec 29, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDTX Restricted Stock Unit Options Exercise $0 -10K -44.44% $0.00 12.5K Dec 29, 2021 Common Stock 10K Direct F3, F4
transaction CDTX Restricted Stock Unit Options Exercise $0 -5.6K -47.06% $0.00 6.3K Dec 29, 2021 Common Stock 5.6K Direct F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was previously granted restricted stock units to vest upon the achievement of certain milestone events that occurred on December 29, 2021.
F2 Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 19, 2021.
F3 Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer.
F4 On September 18, 2017, the Reporting Person was granted restricted stock units totaling 25,000 shares subject to vesting upon the achievement of various milestones.
F5 On January 31, 2019, the Reporting Person was granted restricted stock units totaling 14,000 shares subject to vesting upon the achievement of various milestones.